Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Hepatic Function”

235 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 235 results

Early research (Phase 1)Study completedNCT05916560
What this trial is testing

LY3437943 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 43
Early research (Phase 1)Study completedNCT00651027
What this trial is testing

Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554

Who this might be right for
HEPATITIS C (HCV)
Pfizer 24
Early research (Phase 1)Study completedNCT01185873
What this trial is testing

Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 81
Early research (Phase 1)Study completedNCT06093230
What this trial is testing

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

Who this might be right for
Subjects With Liver Function InjuryNormal Liver Function Subject
Shanghai Vinnerna Biosciences Co., Ltd. 24
Early research (Phase 1)Study completedNCT01513083
What this trial is testing

Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Who this might be right for
Breast Cancer
Hoffmann-La Roche 28
Early research (Phase 1)Study completedNCT05098054
What this trial is testing

Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Takeda 36
Early research (Phase 1)Study completedNCT00432627
What this trial is testing

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 24
Early research (Phase 1)Study completedNCT01919125
What this trial is testing

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 36
Not applicableStudy completedNCT01462552
What this trial is testing

Physician Liver Function Test (LFT) Monitoring for Tykerb Pts

Who this might be right for
Cancer
GlaxoSmithKline 1
Early research (Phase 1)Study completedNCT04993404
What this trial is testing

Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function

Who this might be right for
Hepatic InsufficiencyHealthy Subjects
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 24
Early research (Phase 1)Study completedNCT01670734
What this trial is testing

Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 25
Early research (Phase 1)Study completedNCT06048302
What this trial is testing

PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic Function

Who this might be right for
Hepatic ImpairmentHealthy
NewAmsterdam Pharma 18
Early research (Phase 1)Study completedNCT04154774
What this trial is testing

Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Janssen Research & Development, LLC 18
Early research (Phase 1)Study completedNCT05624710
What this trial is testing

Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Who this might be right for
Renal InsufficiencyKidney Diseases
Incyte Corporation 25
Early research (Phase 1)Looking for participantsNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Early research (Phase 1)Study completedNCT05391724
What this trial is testing

Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects

Who this might be right for
Hepatic Impairment
Jazz Pharmaceuticals 25
Early research (Phase 1)Ended earlyNCT05209295
What this trial is testing

Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Who this might be right for
Hepatic InsufficiencyNeoplasms
Bristol-Myers Squibb 2
Early research (Phase 1)Study completedNCT05661344
What this trial is testing

Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 28
Early research (Phase 1)Study completedNCT02621047
What this trial is testing

Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib

Who this might be right for
Hepatic Impairment
Hoffmann-La Roche 28
Early research (Phase 1)Study completedNCT04482270
What this trial is testing

Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 26
Load More Results